PRELUDE CAPITAL MANAGEMENT, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 135 filers reported holding THERAPEUTICSMD INC in Q4 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2021$4,000
-71.4%
11,000
+6.8%
0.00%
Q1 2021$14,000
+1300.0%
10,300
+1371.4%
0.00%
Q3 2020$1,0000.0%7000.0%0.00%
Q2 2020$1,000
-66.7%
700
-50.7%
0.00%
Q4 2019$3,000
-50.0%
1,421
-9.9%
0.00%
Q3 2019$6,000
+50.0%
1,577
-2.7%
0.00%
Q2 2019$4,000
+300.0%
1,620
+639.7%
0.00%
Q4 2018$1,000
-96.4%
219
-91.9%
0.00%
-100.0%
Q4 2015$28,000
-92.3%
2,700
-96.1%
0.00%
-93.3%
Q4 2013$365,00070,0000.06%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2021
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 3,560,816$2,641,0000.48%
Rubric Capital Management LP 5,344,302$3,962,0000.11%
Birchview Capital, LP 100,000$74,0000.05%
C WorldWide Group Holding A/S 6,189,834$4,589,0000.05%
MCDONALD PARTNERS LLC 226,000$168,0000.04%
Traynor Capital Management, Inc. 367,991$272,0000.04%
Platform Technology Partners 100,000$74,0000.03%
EMFO, LLC 44,500$33,0000.03%
Knights of Columbus Asset Advisors LLC 365,105$271,0000.02%
Kowal Investment Group, LLC 98,631$73,0000.02%
View complete list of THERAPEUTICSMD INC shareholders